| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 05/24/2000 | EP1002870A1 Androgen- and progesteron-receptor binding Hormone Response Element |
| 05/24/2000 | EP1002862A1 Methods of diagnosing or treating neurological diseases |
| 05/24/2000 | EP1002799A1 Optically pure androgen mediator |
| 05/24/2000 | EP1002797A1 4,5-DIHYDRO- 1H]-BENZ g]INDAZOLE-3-CARBOXYLIC ACID DERIVATIVES |
| 05/24/2000 | EP1002104A1 Novel metalloprotease |
| 05/24/2000 | EP1001970A1 Dipeptide derivatives as growth hormone secretagogues |
| 05/24/2000 | EP1001797A1 Soya extract, process for its preparation and pharmaceutical composition |
| 05/24/2000 | EP1001788A1 Boron carbohydrate complexes and uses thereof |
| 05/24/2000 | EP1001776A1 Aroylpiperazines for modulating sexual activity |
| 05/24/2000 | EP1001775A1 Medicine containing yohimbine and arginine for treating erectile dysfunction |
| 05/24/2000 | EP1001771A1 A medicament against infertility and for increasing fertility |
| 05/24/2000 | CN1254288A Condensation polymer composition for preventing pregnancy |
| 05/24/2000 | CN1254283A Pregnan-3-ol-20-ones |
| 05/24/2000 | CN1253828A Chinese medicine preparation for curing gynecologic inflammation and its preparation method |
| 05/24/2000 | CN1253824A Chinese medicine preparation for curing hyperplasia of mamary glands and its preparation method |
| 05/24/2000 | CN1253808A Chinese medicine abortifacient |
| 05/24/2000 | CN1052725C Tricyclic vasopressin antagonists |
| 05/24/2000 | CN1052723C Bicyclic aromatic compounds as therapeutic agents, its preparing method and drug composition containing said compound |
| 05/24/2000 | CN1052655C Human relaxin formulation |
| 05/24/2000 | CN1052635C Contraceptive medicine |
| 05/23/2000 | US6066735 Treatment of erectile dysfunction |
| 05/23/2000 | US6066717 RsbW-1 protein |
| 05/23/2000 | US6066644 Treatment of various cns disorders |
| 05/23/2000 | US6066502 Endothelin converting enzyme (ECE) |
| 05/23/2000 | US6066324 Carboxyl terminal of papilloma virus L1 region is not required for formation of virus-like particles |
| 05/18/2000 | WO2000028027A2 Corticosteroid synthesis-associated genes |
| 05/18/2000 | WO2000027848A1 Pyrazolopyrimidinone derivatives for the treatment of impotence |
| 05/18/2000 | WO2000027845A1 Spiro-indolines as y5 receptor antagonists |
| 05/18/2000 | WO2000027822A2 Tricyclic pyrazole derivatives |
| 05/18/2000 | WO2000027815A2 N-substituted azacycles, their preparation and their use as orl-1 receptor ligands |
| 05/18/2000 | WO2000027805A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 05/18/2000 | WO2000027414A2 Inhibition of the formation of vascular hyperpermeability |
| 05/18/2000 | WO2000027389A1 Oxy-vanadium (iv) complexes having spermicidal activity |
| 05/18/2000 | CA2350714A1 Spiro-indolines as y5 receptor antagonists |
| 05/18/2000 | CA2350235A1 Tricyclic pyrazole derivatives |
| 05/18/2000 | CA2349761A1 Corticosteroid synthesis-associated genes |
| 05/18/2000 | CA2347916A1 Inhibition of the formation of vascular hyperpermeability |
| 05/18/2000 | CA2318162A1 Oxy-vanadium (iv) complexes having spermicidal activity |
| 05/17/2000 | EP1000621A2 Use of 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz (CD) indoles for treating motion sickness and vomiting |
| 05/17/2000 | EP1000158A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 05/17/2000 | EP1000048A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 05/17/2000 | EP1000035A1 Substituted 6-phenylphenanthridines |
| 05/17/2000 | EP1000018A2 Urokinase inhibitors |
| 05/17/2000 | CN1253561A Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5) for treatment of sexual dysfunction |
| 05/17/2000 | CN1253560A Sulfonamides for treatment of endothelin-mediated disorders |
| 05/17/2000 | CN1252992A Carboprost methylate preparation able to be absorbed via oral mucosa and its preparing process |
| 05/17/2000 | CN1052414C Medicinal liquor for invigorating kidney and strengthening Yang and its process |
| 05/17/2000 | CN1052406C Health-care nourishment series for postpartum and its producing method |
| 05/16/2000 | US6063797 γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor |
| 05/16/2000 | US6063620 Type I angiotensin II receptor specific monoclonal antibodies and hybridomas |
| 05/16/2000 | US6063395 Sustained rlease |
| 05/16/2000 | CA2215020C Tetrazolyl-substituted quinuclidines as substance p antagonists |
| 05/11/2000 | WO2000026372A1 Myosin heavy chain homolog |
| 05/11/2000 | WO2000026245A2 Human membrane transport proteins |
| 05/11/2000 | WO2000026243A2 Transmembrane 4 proteins |
| 05/11/2000 | WO2000026236A2 Method of modulating cell differentiation or neoplastic transformation by altering cadherin-11 expression or function |
| 05/11/2000 | WO2000026224A2 Novel macrolide antibiotics |
| 05/11/2000 | WO2000026216A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 05/11/2000 | WO2000026202A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/11/2000 | WO2000025792A1 Estradiol-containing adhesive preparation |
| 05/11/2000 | WO2000025781A1 Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation |
| 05/11/2000 | WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 05/11/2000 | WO2000008015A3 Fsh mimetics for the treatment of infertility |
| 05/11/2000 | WO2000007581A3 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
| 05/11/2000 | WO2000007542A3 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance p |
| 05/11/2000 | WO1999051214A3 Progestogen-only contraceptive kit |
| 05/11/2000 | CA2349818A1 Membrane transport proteins |
| 05/11/2000 | CA2349567A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 05/11/2000 | CA2349212A1 Myosin heavy chain homolog |
| 05/11/2000 | CA2348910A1 Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation |
| 05/11/2000 | CA2347650A1 Transmembrane 4 proteins |
| 05/11/2000 | CA2347188A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/10/2000 | EP0998940A1 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues |
| 05/10/2000 | EP0998471A1 Substituted heterocyclic compounds, method for preparing and compositions containing same |
| 05/10/2000 | EP0998289A1 Composition and method for supplementing testosterone in women with symptoms of testosterone deficiency |
| 05/10/2000 | EP0998274A2 Microdose therapy of vascular conditions by no donors |
| 05/10/2000 | EP0708647B1 Combination of a progestational agent and a nitric oxide synthase substrate and/or donor for the treatment of preeclampsia and preterm labor |
| 05/10/2000 | EP0623019B1 Docosahexaenoic acid based drugs, for use as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain, and preparation processes. |
| 05/10/2000 | CN1252275A Breast pumping up massage oil |
| 05/10/2000 | CN1052238C Conception promoting 19,11 overbridge estratrene |
| 05/10/2000 | CN1052237C Steroids with 17-spiromethylene lactone or ortho -hydroxyl inner ether base |
| 05/10/2000 | CN1052218C Process for preparing substituted 2-amino tetrahydronaphthalenes and 3-aminochromans |
| 05/09/2000 | US6060494 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 05/09/2000 | US6060479 Quinazoline-4-one AMPA antagonists |
| 05/09/2000 | US6060475 Substituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses thereof |
| 05/09/2000 | US6060446 Protein and carnosine, glutathione, and/or cyclo-histidine-proline |
| 05/09/2000 | US6060270 Central lumen bordered by polarized epithelium and produced by culturing in all-trans retinoic acid, transforming growth factor-beta-1 and either epidermal growth factor or transforming growth factor-alpha; for kidney disorders |
| 05/09/2000 | US6060250 Human transferases |
| 05/09/2000 | CA2112239C Enantiomeric hydroxylated xanthine compounds |
| 05/04/2000 | WO2000024911A2 Human phospholipases |
| 05/04/2000 | WO2000024890A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
| 05/04/2000 | WO2000024755A1 Ovary-specific genes and proteins |
| 05/04/2000 | WO2000024745A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 05/04/2000 | WO2000024743A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 05/04/2000 | WO2000024741A2 Dihydropyridine compounds and their use as potassium channel openers |
| 05/04/2000 | WO2000024727A1 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI2 DERIVATIVE AND DRUGS CONTAINING THE SAME |
| 05/04/2000 | WO2000024393A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| 05/04/2000 | WO2000024383A1 Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor |
| 05/04/2000 | WO2000024373A1 O/w emulsion comprising an hydroxylated oil |
| 05/04/2000 | WO2000007997A8 IMIDAZOLES AND RELATED COMPOUNDS AS α1A AGONISTS |